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Abstract
Background: Hypertension is a complex chronic condition characterized by elevated arterial blood pressure.
Management of hypertension includes non-pharmacologic strategies, which may include techniques that effectively
reduce autonomic sympathetic activity. Respiratory exercises improve autonomic control over cardiovascular system
and attenuate muscle metaboreflex. Because of these effects, respiratory exercises may be useful to lower blood
pressure in subjects with hypertension.
Methods/design: This randomized, double-blind clinical trial will test the efficacy of inspiratory muscle training in
reducing blood pressure in adults with essential hypertension. Subjects are randomly allocated to intervention or
control groups. Intervention consists of inspiratory muscle training loaded with 40 % of maximum inspiratory
pressure, readjusted weekly. Control sham intervention consists of unloaded exercises. Systolic and diastolic blood
pressures are co-primary endpoint measures assessed with 24 h ambulatory blood pressure monitoring. Secondary
outcome measures include cardiovascular autonomic control, inspiratory muscle metaboreflex, cardiopulmonary
capacity, and inspiratory muscle strength and endurance.
Discussion: Previously published work suggests that inspiratory muscle training reduces blood pressure in persons
with hypertension, but the effectiveness of this intervention is yet to be established. We propose an adequately
sized randomized clinical trial to test this hypothesis rigorously. If an effect is found, this study will allow for the
investigation of putative mechanisms to mediate this effect, including autonomic cardiovascular control and
metaboreflex.
Trial registration: ClinicalTrials.gov NCT02275377. Registered on 30 September 2014.
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Background
Essential hypertension is a multifactorial disease charac-
terized by chronically elevated systolic blood pressure
(≥140 mmHg) or diastolic blood pressure (≥90 mmHg)
[1–4]. Hypertension is a major risk factor for target-
organ dysfunction, cardiovascular disease, and prema-
ture mortality [3, 4]. The prevalence of hypertension in
Brazil has been decreasing over the past three decades,
but 30 % of persons over 18 years of age still bear this
condition [5].
The autonomic nervous system is a major determinant
of systemic blood pressure and it might be a therapeutic
target in hypertension [6, 7]. Hyperactivity of the sympa-
thetic nervous system plays a role in abnormal elevations
of blood pressure [6–8]. Blood pressure variability is in-
creased in hypertensive persons. This phenomenon has
been linked to desensitization of baroreceptors, leading
to an anomalous autonomic response [9, 10]. Beta-
adrenergic receptor blockers are an example of an effect-
ive pharmacologic approach to target the autonomic
nervous system in hypertension [11].
Respiratory exercises are a non-pharmacologic inter-
vention that might modulate autonomic nervous system
activity and reduce blood pressure [12, 13]. An exercise
composed of controlled respiratory patterns with a slow
respiratory rate has improved autonomic control and re-
duced blood pressure in hypertensive subjects [12]. In-
spiratory muscle training – a different modality of
respiratory exercise – was tested in one randomized
clinical trial that included 13 participants [13]; in this
study, inspiratory muscle training reduced 24 h systolic
blood and diastolic blood pressure by 7.9 and 5.5 mmHg,
respectively, and also improved autonomic cardiovascu-
lar control. Respiratory muscle training might also have
reduced sympathetic activity through attenuation of
muscle metaboreflex [14, 15].
Methods/design
Study aim
This study aims to test the efficacy of inspiratory muscle
training in reducing blood pressure in subjects with es-
sential hypertension. It will further investigate the effects
of this intervention on inspiratory metaboreflex – a pu-
tative mechanism for blood pressure reduction. The
conceptual hypothesis is that inspiratory muscle training
reduces mean 24 h blood pressure through modulation
of sympathetic nervous system activity and muscle
metaboreflex.
Study design
This is a double-blind, parallel-group, sham-controlled
randomized clinical trial. Participants are randomly
assigned to receive inspiratory muscle training with a load
equivalent to 40 % of maximum inspiratory pressure or in-
spiratory muscle training sham (no load) for 8 weeks. The
study flowchart is depicted in Fig. 1. Participants are
followed on weekly visits. Study outcomes are assessed at
the end of the eighth week. The study timeline is summa-
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Fig. 1 Study flow diagram. BP blood pressure, ABPM ambulatory blood pressure monitoring, MIP maximum inspiratory pressure; R randomization
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information on methods of assessment and protocols can
be found.
Study context
Participants will be recruited from patients receiving
follow-up care at the hypertension clinic or the primary
health care center at the Hospital de Clínicas de Porto
Alegre, a tertiary, university-affiliated teaching hospital.
Public announcements (radio, newspapers, and website)
will also call for volunteers among residents of the city
of Porto Alegre.
Eligibility criteria
The study includes both male and female subjects,
aged ≥35 and <65 years, previously diagnosed with
essential hypertension, with a systolic blood pressure
≥140 mmHg or diastolic blood pressure ≥90 mmHg.
Subjects receiving no pharmacologic therapy or taking
only a thiazide diuretic are eligible to enter the study.
Participants must have body mass index <30 kg/m2
[16], practice <150 min of moderate or intense phys-
ical activity per week, according to the International
Physical Activity Questionnaire [17, 18], and have in-
spiratory muscle strength ≥70 % of predicted [19].
Participants are excluded from the study if they have:
office blood pressure ≥160/100 mmHg; severe dyspnea;
diabetes mellitus; orthopedic, musculoskeletal, or neuro-
logic limitations; significant cognitive impairment; a
current or past history of deep venous thrombosis; a his-
tory of myocardial infarction or stroke in the previous
6 months; congestive heart failure; unstable angina; or
pulmonary disease of any etiology (including asthma and
chronic obstructive pulmonary disease); or if they are ac-
tive smokers. Women who are pregnant or breastfeeding
are excluded from this study. Subjects are not eligible if
they participated in another clinical trial in the previous
30 days, or if there is any other condition that might im-
pair their ability to participate in the study or follow the
protocol, at the discretion of the recruiter.
Participants are also directed not to change pharmaco-
logic or non-pharmacologic treatment for hypertension
(including changes in prescription or changes in the of
level physical activity) during their participation in this
study.
Study outcomes
The co-primary outcomes measures are changes from
baseline to end of study in mean 24 h systolic and diastolic
blood pressure, as evaluated by ambulatory blood pressure
monitoring.
Secondary outcome measures are changes from base-
line to end of study in mean daytime systolic and dia-
stolic blood pressure; changes from baseline to end of
study in mean nighttime systolic and diastolic blood
pressure; heart rate variability; systolic blood pressure
variability; aerobic capacity; inspiratory metaboreflex;
and autonomic control.
Randomization, allocation, blinding, and confidentiality
A randomization sequence has been generated using Ran-
domization.org in blocks of four to either group 1 – in-
spiratory muscle training with 40 % of maximal inspiratory
pressure – or group 2 – sham inspiratory muscle training.
An independent person not involved in this study pos-
sesses the computer-generated randomization sequence. A
research assistant not involved in participant assessment
obtains the code and sets the load in each device, accord-
ing to randomization. A black tape hides the loading spring
from the participant and from the investigators assessing
outcomes.
There are no foreseen circumstances when un-blinding
is permissible. When data collection is completed, the per-
son responsible for the randomization list will provide as-
signment information to the investigators. Patient’s forms
and other data sources are kept in a locked cabinet. Data
are anonymized when entered into the database to protect
confidentiality. Only investigators formally associated with
the project will have access to the final study database.
Studied variables and methods of assessment
Participants are assessed as described in Additional file 1.
Briefly, baseline physical activity is quantified using the
International Physical Activity Questionnaire long form
[20]. Body mass index is calculated as mass (kg) divided
by the square of the height (m) and categorized as recom-
mended by the World Health Organization [21]. Ambula-
tory blood pressure monitoring is performed with
Spacelabs 90207 devices (Redmond, WA, USA). The
protocol includes blood pressure measurement every
15 min during the daytime (6 a.m. to 10 p.m.) and every
20 min during the nighttime (10 p.m. to 6 a.m.) [22].
Functional capacity is assessed during exercise through O2
and CO2 expiration fraction in a metabolic system.
Maximum oxygen consumption in each breath is re-
corded in ml/(Kg/min) [23, 24].
Maximum inspiratory and maximum expiratory pres-
sure serve as indicators of inspiratory and expiratory
muscle strength, respectively. Maximum inspiratory and
maximum expiratory pressure are assessed using a
digital pressure manometer (MVD-300, Microhard Sys-
tem, Globalmed, Porto Alegre, Brazil) [25, 26].
Inspiratory muscle endurance is determined using the
incremental test proposed by Martyn et al. [27] using
the Powerbreathe Plus® system (London, UK). The test is
stopped when the subject cannot open the inspiratory
valve or desires to stop the test owing to respiratory ex-
haustion (quantified using the modified Borg scale).
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Blood pressure variability, heart rate variability, and the
cardiac vagal tone are assessed to evaluate autonomic car-
diovascular control. Non-invasive continuous blood pres-
sure curves, heart rate, and electrocardiogram tracing are
obtained simultaneously at a frequency of 1000 Hz using a
Biopac MP150 (Biopac, California, EUA). Data are regis-
tered in a computer with biologic signal conversion
capabilities.
The muscle metaboreflex is the adaptive blood flow re-
distribution from the peripheral circulation into the vas-
cular bed of metabolically active (exercised) muscles
[28]. The metaboreflex intensity is inversely related to
one’s fitness. Inspiratory muscle metaboreflex is assessed
by causing diaphragmatic fatigue and detecting periph-
eral blood flow reduction [28, 29]. Monitored parame-
ters include: oxygen saturation, carbon dioxide partial
expiratory tension, mean arterial pressure, and venous
occlusion plethysmography. A detailed protocol can be
found in Additional file 1.
Intervention
Participants are extensively instructed on how to per-
form home-based inspiratory muscle training assisted by
a Power Breathe Plus® (London, UK) device. For partici-
pants’ safety, research staff are responsible for device hy-
giene before and after the intervention period. To
perform the exercise training, subjects should be seated,
obstruct the nose with a nasal clip, and breathe in and
out through the mouthpiece. The goal is to keep dia-
phragmatic breathing at 10–15 respirations per minute
for a total of 30 min per day, 7 days a week.
Participants receiving active inspiratory muscle train-
ing (intervention group) perform the exercises with a
load equivalent to 40 % of maximal inspiratory pressure.
Those receiving the sham intervention (the control
group) follow the same instructions but have no load ap-
plied to the respiratory exercises. The sham intervention
was chosen as comparator because it is the most similar
intervention available. It allows for blinding of investiga-
tors and participants, and is not expected to reproduce
the effects of loaded exercises.
The complete study protocol consists of 56 daily train-
ing sessions completed over 8 weeks. During the sched-
uled weekly visit to the study center, participants are
questioned about possible discomforts associated with
the intervention, which may include: headaches, nausea,
intense muscle fatigue, muscle cramps, and chest pain.
Respiratory muscle strength is then reassessed; inspira-
tory threshold loading is adjusted accordingly, keeping a
40 % maximum inspiratory load for the intervention
group throughout the study. The staff member who re-
ceives information about treatment allocation and ad-
justs the load neither participates in any assessments nor
communicates with participants.
Participants in both groups receive a journal to regis-
ter date, time, duration of training session, and possible
symptoms or discomforts associated to the intervention.
This serves as a mean to stimulate and estimate adher-
ence to intervention. Adherence to the protocol is also
reinforced on weekly follow-up phone calls.
Sample size calculation
Sample size was estimated based on a small randomized
clinical trial on the effect of inspiratory muscle training
on blood pressure of hypertensive subjects in Brazil [13].
That study found an 8 mmHg difference in systolic
blood pressure between the active treatment and the
control group (standard deviation, 10 mmHg). To detect
this difference with power of 80 %, and assuming an
alpha error of 5 %, the study should include 26 partici-
pants per group. We opted for a 20 % inflation of this
number to account for loss of follow-up and consent
withdrawal – therefore, a total of 60 participants will be
included and assigned to either intervention or sham
treatment.
Data management and statistical analysis plan
Data recorded in printed forms are kept in locked cabi-
nets. Information is entered on Microsoft Excel spread-
sheets by one person and reviewed by another. Numeric
continuous variables, including blood pressure in the
primary outcome measures, will be described as mean ±
standard deviation or as median (interquartile range).
Comparison between groups will be performed using
Student’s t test or the Mann–Whitney U test, depending
on variable distribution. As a superiority trial, differences
in autonomic cardiovascular control and metaboreflex
between groups will be tested with two-sided repeated-
measures ANOVA. Results will be analyzed as per
intention-to-treat. Participants who drop out and do not
complete outcome assessment will be compared with
those who completed the protocol but their data will be
excluded from analysis. Statistical significance will be con-
sidered for P < 0.05. All analyses will be performed using
PASW Statistics 18® (International Business Machines
Corp., New York, NY).
Results communication
A summary of the main findings in non-technical lan-
guage will be sent to participants after study completion.
Scientific papers written according to the CONSORT
recommendations will be submitted for peer-reviewed
publication. Study results will also be communicated as
abstracts and presentations in local, national, and inter-
national scientific meetings.
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Discussion
The effect of inspiratory muscle training on blood pres-
sure in hypertensive individuals is not yet established. A
significant reduction in blood pressure was observed in
a small randomized clinical trial with six and five subject
allocated to intervention and control groups, respectively
[13]. Although these findings do not provide enough evi-
dence to support the efficacy of inspiratory muscle train-
ing in blood pressure control, they are encouraging. We
propose an adequately sized randomized clinical trial to
test the hypothesis that inspiratory muscle training
reduces blood pressure in persons with hypertension. If
the hypothesis is confirmed, this study will also allow for
investigation of putative mechanisms mediating such an
effect. We will assess the effects of inspiratory muscle
training on autonomic cardiovascular control and meta-
boreflex in subjects with hypertension – data that, to the
best of our knowledge, are lacking in the medical
literature.
The evaluation of inspiratory muscle metaboreflex is
one of the strengths of this study. Inspiratory muscle
training attenuated the metaboreflex in healthy subjects
[30] and in persons with chronic heart failure [31]. In
healthy subjects, decreased inspiratory work through
assisted ventilation increases exercise time on a cycle
ergometer by 14 % [32]; a similar intervention has been
shown to attenuate quadriceps fatigue during exercise
[9]. This effect is probably due to inhibition of inspira-
tory muscle metaboreflex [10].
The effects of inspiratory muscle training deserve to
be better understood given the potential to help control
blood pressure in hypertensive patients. The results of
this study will provide evidence on the effects of inspira-
tory muscle training on blood pressure, in addition to
inspiratory muscle metaboreflex, autonomic cardiovas-
cular control, and other physiologic and metabolic as-
pects. These data will provide mechanistic insights, as
well as useful clinical information for the management
of hypertension.
Trial status
The trial is enrolling participants.
Additional file
Additional file 1: Supplementary material. Methods for assessment of
study outcomes and other variables. Figure S1. Schedule of enrollment,
intervention, and assessments. Figure S2. Inspiratory muscle
metaboreflex induction protocol flowchart. (DOCX 362 kb)
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